-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 Lnf18chhEsTWM4vbbWZEaQL1zHY4JWZdktxqWaEoDdmf9H8ZrzgSXC88zZwoEzmS
 cNwLZxF/vLStF8ePTF8v/g==

<SEC-DOCUMENT>0000950103-09-000053.txt : 20090109
<SEC-HEADER>0000950103-09-000053.hdr.sgml : 20090109
<ACCEPTANCE-DATETIME>20090109191110
ACCESSION NUMBER:		0000950103-09-000053
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20090107
FILED AS OF DATE:		20090109
DATE AS OF CHANGE:		20090109

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GENELABS TECHNOLOGIES INC /CA
		CENTRAL INDEX KEY:			0000874443
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				943010150
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			0131

	BUSINESS ADDRESS:	
		STREET 1:		505 PENOBSCOT DR
		CITY:			REDWOOD CITY
		STATE:			CA
		ZIP:			94063
		BUSINESS PHONE:		6503969500

	MAIL ADDRESS:	
		STREET 1:		505 PENOBSCOT DR
		CITY:			REDWOOD CITY
		STATE:			CA
		ZIP:			94063

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			MORGAN STANLEY
		CENTRAL INDEX KEY:			0000895421
		STANDARD INDUSTRIAL CLASSIFICATION:	SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211]
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-19222
		FILM NUMBER:		09519996

	BUSINESS ADDRESS:	
		STREET 1:		1585 BROADWAY
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10036
		BUSINESS PHONE:		212-761-4000

	MAIL ADDRESS:	
		STREET 1:		1585 BROADWAY
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10036

	FORMER NAME:	
		FORMER CONFORMED NAME:	MORGAN STANLEY DEAN WITTER & CO
		DATE OF NAME CHANGE:	19980326

	FORMER NAME:	
		FORMER CONFORMED NAME:	DEAN WITTER DISCOVER & CO
		DATE OF NAME CHANGE:	19960315
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>dp12261_4-gnlbex.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0303</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2009-01-07</periodOfReport>

    <notSubjectToSection16>1</notSubjectToSection16>

    <issuer>
        <issuerCik>0000874443</issuerCik>
        <issuerName>GENELABS TECHNOLOGIES INC /CA</issuerName>
        <issuerTradingSymbol>GNLB</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0000895421</rptOwnerCik>
            <rptOwnerName>MORGAN STANLEY</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>1585 BROADWAY</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10036</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2009-01-07</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>S</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>5374343</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>1.30</value>
                    <footnoteId id="F2"/>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>D</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>0</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>By Subsidiary</value>
                    <footnoteId id="F1"/>
                </natureOfOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">The reported securities are held directly by certain funds (each, a &quot;Fund&quot; and collectively, the &quot;Funds&quot;) managed by indirect
 subsidiary entities of the reporting person. FrontPoint Partners LLC (&quot;FPP&quot;), an indirect wholly owned subsidiary of the
 reporting person is the parent company of each entity that is the investment manager of one or more of the Funds. This form
 is filed without prejudice to the reporting person's position that none of the Funds nor FPP or any of its subsidiaries, nor
 the reporting person, individually or in aggregate, are required to file beneficial ownership reports under Section 16(a) of
 the a Securities Exchange Act of 1934, and should not be construed or interpreted as a concession or admission that such
 reports are required.</footnote>
        <footnote id="F2">The completion of the tender offer by Gemstone Acquisition Corporation (&quot;Purchaser&quot;), a wholly-owned subsidiary of SmithKline
 Beecham Corporation and a wholly-owned subsidiary of GlaxoSmithKline PLC, contemplated by the Agreement and Plan of Merger
 (the &quot;Merger Agreement), dated as of October 29, 2008, occurred on January 6, 2009. Each share of common stock, no par
 value, of the Issuer held by the Reporting Person was accepted for payment by the Purchaser at a price of $1.30 per share,
 on January 7, 2009.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Dennine Bullard, By: Morgan Stanley, By: Dennine Bullard, Authorized Signatory</signatureName>
        <signatureDate>2008-01-09</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----